Serologic testing for syphilis in the United States: A cost-effectiveness analysis of two screening algorithms

Sexually Transmitted Diseases

Volumn 38, Issue 1, 2011, Pages 1-7

  Owusu Edusei, Kwame ^a   Peterman, Thomas A ^a   Ballard, Ronald C ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLUTINATION TEST; ARTICLE; CHEMOLUMINESCENCE; COHORT ANALYSIS; COMPARATIVE STUDY; CONCURRENT INFECTION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ECONOMIC ASPECT; FOLLOW UP; HEALTH CARE SYSTEM; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; NONHUMAN; OUTCOME ASSESSMENT; REAGIN TEST; SCREENING; SYPHILIS; SYPHILIS SEROLOGY; TREPONEMA PALLIDUM; UNITED STATES;

ALGORITHMS; COST-BENEFIT ANALYSIS; HUMANS; MASS SCREENING; PLASMA; REAGINS; SENSITIVITY AND SPECIFICITY; SYPHILIS; SYPHILIS SERODIAGNOSIS; TREATMENT OUTCOME; TREPONEMA PALLIDUM; UNITED STATES;

EID: 78650850503     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3181ec51f1     Document Type: Article

References (30)

1. Centers for Disease Control and Prevention. Syphilis testing algorithms using treponemal tests for initial screening-four laboratories, New York City, 2005-2006. Morb Mortal Wkly Rep 2008;57: 872-875.
2. Ebel A, Vanneste L, Cardinaels M, et al. Validation of the INNO-LIA syphilis kit as a confirmatory assay for Treponema pallidum antibodies. J Clin Microbiol 2000; 38:215-219.
3. Aberle-Grasse J, Orton SL, Notari E, et al. Predictive value of past and current screening tests for syphilis in blood donors: Changing from a rapid plasma reagin test to an automated specific treponemal test for screening. Transfusion 1999; 39:206-211.
4. Rusnak JM, Butzin C, McGlasson D, et al. False-positive rapid plasma reagin tests in human-immunodeficiency-virus infection and relationship to anticardiolipin antibody and serum immuno-globulin levels. J Infect Dis 1994; 169:1356-1359.
5. Calonge N. United States Preventive Services Task Force. Screening for syphilis infection: Recommendation statement. Ann Fam Med 2004; 2:362-365. (Pubitemid 39107895)
6. Larsen SA, Pope V, Johnson RE, et al, eds. A manual of Tests for Syphilis, 9th ed. Arlington, VA: Am Public Health Association, 1998.
7. Egglestone SI, Turner AJ; PHLS Syphilis Serology Working Group. Serological diagnosis of syphilis. Commun Dis Publ Health 2000; 3:158-162.
8. Larsen SA, Steiner BM, Rudolph AH. Laboratory diagnosis and interpretation of tests for syphilis. Clin Microbiol Rev 1995; 8:1-21.
9. Young H. Syphilis-new diagnostic directions. Int J STD AIDS 1992; 3:391-413.
10. Centers for Disease Control and Prevention. Sexually transmitted disease treatment guidelines, 2006. MMWR Recomm Rep 2006; 55:1-94.
11. Lukehart SA. Biology of treponemes. In: Holmes KK, Sparling PF, Stamm WE, et al, eds, Sexually Transmitted Disease. New York, NY: McGraw Hill, 2008:647-659.
12. Owusu-Edusei K Jr, Koski KA, Ballard RC. The tale of two syphilis serologic tests-treponemal and nontreponemal: does the order matter? Paper presented at: 11th International Union against Sexually Transmitted Infections (IUSTI) World Congress, 2009, Cape Town, South Africa.
13. Clinical Diagnostic Laboratory Fee Schedule. Washington, DC: Centers for Medicare & Medicaid Services, 2009. Available at http://www.cms.hhs.gov/ apps/ama/license.asp?file=/ClinicalLabFee Sched/downloads/09CLAB.ZIP. Accessed December 18, 2009.
14. Rydzak CE, Goldie SJ. Cost-effectiveness of rapid point-of-care prenatal syphilis screening in Sub-Saharan Africa. Sex Transm Dis 2008; 35:775-784.
15. Institute of Health Economics, Anderson C, Jacobs P, et al. Cost-Effectiveness in the Detection of Syphilis. Alberta, Canada: Institute of Health Economics, 2007.
16. Chuck A, Ohinmaa A, Tilley P, et al. Cost effectiveness of enzyme immunoassay and immunoblot testing for the diagnosis of syphilis. Int J STD AIDS 2008; 19:393-399.
17. Blandford JM, Gift TL, Vasaikar S, et al. Cost-effectiveness of on-site antenatal screening to prevent congenital syphilis in rural Eastern Cape Province, Republic of South Africa. Sex Transm Dis 2007; 34:S61-S66.
18. Clark EG, Danbolt N. The Oslo study of the natural history of untreated syphilis; an epidemiologic investigation based on a restudy of the Boeck-Bruusgaard material; a review and appraisal. Med Clin North Am 1964; 48:613.
19. Kraut JR, Haddix AC, Carande-Kulis V, et al. Cost-effectiveness of routine screening for sexually transmitted diseases among inmates in United States prisons and jails. In: National Commission on Correctional Health Care, ed. The Health Status of Soon-to-be Released Inmates: A Report to Congress. Chicago, IL: Commission on Correctional Health Care, 2002:81-108.
20. Chesson HW, Blandford JM, Gift TL, et al. The estimated direct medical cost of sexually transmitted diseases among American youth, 2000. Perspect Sex Reprod Health 2004; 36:11-19.
21. Gift TL, Malotte K, Ledsky R, et al. A cost-effectiveness analysis of interventions to increase repeat testing in patients treated for gonorrhea or chlamydia at public sexually transmitted disease clinics. Sex Transm Dis 2005; 32:542-549.
22. Clinical Laboratory Fee Schedule. Baltimore, MD: Centers for Medicare and Medicaid Services, 2009. Available at: http://www.cms.hhs. gov/ ClinicalLabFeeSched/02-clinlab.asp#TopOfPage. Accessed December 22, 2008.
23. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002; 51:1-78.
24. Blandford JM, Gift TL. The cost-effectiveness of single-dose azithromycin for treatment of incubating syphilis. Sex Transm Dis 2003; 30:502-508.
25. American Academy of Family Physician, Woodard C, Fisher MA. Drug Treatment of Common STDs: Part I. Herpes, Syphilis, Urethritis, Chlamydia and Gonorrhea. American Academy of Family Physician, 2008. Available at: http://www.aafp.org/afp/ 991001ap/1387.html. Accessed February 10, 2008.
26. Consumer Price Indexes-all Urban Consumers. Washington, DC: United States Department of Labor. Available at: http://www.bls. gov/cpi/home.htm. Accessed January 15, 2010.
27. Siegel JE, Weinstein MC, Russell LB, et al. Recommendations for reporting cost-effectiveness analyses. JAMA 1996; 276: 1339-1341.
28. Siegel JE, Weinstein MC, Russell LB, et al. Consensus statement: Recommendations for reporting cost-effectiveness analyses. Pe-diatr AIDS HIV Infect Fetus Adolesc 1997; 8:130-134.
29. Weinstein MC, Siegel JE, Gold MR, et al. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA 1996; 276:1253-1258.
30. Young H. Syphilis-serology. Dermatol Clin 1998; 16:691-698.